Modeling and Simulation - PK/PD Archives | Page 2 of 44

On-Demand Webinar

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Discover population PK modeling made faster and easier with Phoenix NLME and Pirana in this…

CertaraJanuary 30, 2026

On-Demand Webinar

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

This on demand session demonstrates how Phoenix WinNonlin® and other tools work together within Phoenix®…

CertaraJanuary 27, 2026

Conference

Quantitative Systems Pharmacology Conference

CertaraJanuary 26, 2026

Blog

How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most

Learn how Model-Informed Drug Development strengthens drug asset valuation by reducing uncertainty, predicting clinical performance,…

CertaraJanuary 26, 2026

Webinar

Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA

Danielle PillsburyJanuary 22, 2026

Webinar

Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research

CertaraJanuary 22, 2026

Webinar

Subcutaneous absorption model

CertaraJanuary 22, 2026

Webinar

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

CertaraJanuary 22, 2026

Webinar

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

CertaraJanuary 14, 2026

Announcement

Phoenix® PK/PD Software now Includes Generative AI pharmacokinetic (PK) Reports

New module transforms tables, figures and listings into draft PK reports saving scientists weeks of…

CertaraJanuary 12, 2026

Modeling and Simulation – PK/PD

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

Quantitative Systems Pharmacology Conference

How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most

Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA

Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research

Subcutaneous absorption model

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

Phoenix® PK/PD Software now Includes Generative AI pharmacokinetic (PK) Reports

Newsletter sign up

Quick links

Solutions

Contact